Vancouver, BC (July 8, 2021) – The International Society of Oncology Pharmacy Practitioners (ISOPP) is pleased to announce the publication of its “Position Statement: Role of the oncology pharmacy team in cancer care” in the Journal of Oncology Pharmacy Practice (JOPP).

The Position Statement describes the roles of oncology pharmacists and technicians in cancer patient care and provides information that promotes advocacy, especially for countries where the profession has not yet recognized oncology pharmacy as a specialty.

ISOPP developed the Position Statement to provide guidance on five key areas: 1) oncology pharmacy practice as a pharmacy specialty; 2) contributions to patient care; 3) oncology pharmacy practice management; 4) education and training; and 5) contributions to oncology research and quality initiatives to involve the oncology pharmacy team (OPT).

The Position Statement advocates that: 1) the OPT be fully incorporated into the multidisciplinary healthcare team to optimize patient care; 2) educational and healthcare institutions develop programs to continually educate OPT members; and 3) regulatory authorities develop certification programs to recognize the unique contributions of the OPT in cancer patient care.

View the Position Statement at: https://journals.sagepub.com/doi/full/10.1177/10781552211017199
ISOPP thanks the 23 ISOPP members, led by co-chairs Barry Goldspiel and Lisa Holle, representing 10 countries for writing the Position Statement.

About the International Society of Oncology Pharmacy Practitioners

The International Society of Oncology Pharmacy Practitioners (ISOPP) exists to advance oncology pharmacy care for patients around the world. Through the society’s Symposia, journal (JOPP), newsletters and website, we connect our members with leading edge oncology knowledge, best practices and essential professional networks. Oncology pharmacists from more than 30 countries are members. Together we inspire the global oncology pharmacy community to take action, deliver enhanced professional development resources, and advocate for our profession out of a shared passion for helping cancer patients.

Creating this Position Statement aligns with ISOPP’s strategic goals to engage members around the world to advance oncology pharmacy practice and to provide information that promotes advocacy, especially for countries where the profession has not yet recognized oncology pharmacy as a specialty.